Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial Results

CAMBRIDGE, Mass., Feb. 17, 2021 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ:BPMC) today reported financial results and provided a business update for the fourth quarter and full year ended December 31, 2020. “Last year was transformational for Blueprint Medicines, with four…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.